Search

everythinglearnresearchcommunity

for

Search:↓

A critically ill boy experienced hair loss likely due to the stress of his medical treatments, but his hair regrew completely in 1.5 months.

FGF18 treatment during hair's resting phase can protect against hair loss from radiation.

Examining scalp tissue under a microscope helps diagnose and understand hair loss diseases.

LHTric-1 is a specific antibody useful for studying hair and nail formation.

Certain dietary supplements can improve hair health.

SPARC likely aids in tissue remodeling during the hair cycle, not in starting new hair growth phases.

Androgens affect hair growth and shedding, with genetic and non-genetic factors influencing baldness.

Chrysanthemum zawadskii extract may help treat hair loss by promoting hair growth and affecting growth factors.

PRP therapy significantly improves hair growth and density in men with androgenic alopecia.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

The study found that Short Anagen Syndrome results in short hair growth not due to hair fragility, and hair may grow longer after puberty.

The "color-transition sign" helps tell apart alopecia areata incognita from telogen effluvium by looking at hair color changes.

Macrophage-stimulating protein helps hair grow and can start hair growth phase in mice and human hair samples.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Tiny particles from stem cells help activate hair growth cells and encourage hair growth in mice without being toxic.

GasderminA3 is important for normal hair cycle transitions by controlling Wnt signaling.

Obese mice with a leptin gene mutation have a longer resting phase in their hair cycle, which may help understand certain hair loss conditions.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

The paper suggests that telogen effluvium, a type of hair loss, may be a long-lasting condition triggered by stress or illness in people whose hair growth is unusually synchronized.

The peptide GPIGS helps hair cells grow and speeds up hair regrowth in mice.

COVID-19 recovery can lead to temporary hair loss called telogen effluvium.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Understanding different types of hair loss helps in accurate diagnosis and treatment.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Calcium reduces involucrin in rat hair bulbs but doesn't affect filaggrin and Kdap.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Hair is thinner near the scalp in acute hair shedding conditions.